Stockscreener 앱 받기
15.75
3.21%
0.49
시간 외 거래:
15.86
0.11
+0.70%
전일 마감가:
$15.26
열려 있는:
$15.63
하루 거래량:
1.07M
Relative Volume:
1.02
시가총액:
$1.38B
수익:
$17.49M
순이익/손실:
$-78.50M
주가수익비율:
-13.12
EPS:
-1.2
순현금흐름:
$-52.85M
1주 성능:
-2.30%
1개월 성능:
+16.93%
6개월 성능:
+48.17%
1년 성능:
+30.60%
1일 변동 폭
$15.33
$16.27
1주일 범위
$14.97
$16.27
52주 변동 폭
$8.26
$16.81
Liquidia Corp Stock (LQDA) Company Profile
명칭
Liquidia Corp
전화
919.328.4400
주소
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
LQDA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
15.75 | 1.38B | 17.49M | -78.50M | -52.85M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
439.37 | 128.45B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.63 | 65.17B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
560.90 | 40.09B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.19 | 35.67B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
233.25 | 27.44B | 3.81B | -644.79M | -669.77M | -6.24 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-20 | 개시 | Wells Fargo | Overweight |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-08-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-08-16 | 개시 | Raymond James | Outperform |
| 2024-06-25 | 개시 | Oppenheimer | Perform |
| 2024-01-05 | 재확인 | Needham | Buy |
| 2022-09-19 | 재개 | Wedbush | Underperform |
| 2022-09-01 | 다운그레이드 | Wedbush | Neutral → Underperform |
| 2022-07-22 | 개시 | Ladenburg Thalmann | Buy |
| 2022-05-31 | 개시 | BTIG Research | Buy |
| 2022-05-26 | 개시 | BofA Securities | Buy |
| 2020-12-04 | 개시 | H.C. Wainwright | Buy |
| 2020-11-20 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2018-11-08 | 재개 | Jefferies | Buy |
| 2018-09-05 | 개시 | Wedbush | Outperform |
| 2018-08-20 | 개시 | Jefferies | Buy |
| 2018-08-20 | 개시 | Needham | Buy |
모두보기
Liquidia Corp 주식(LQDA)의 최신 뉴스
Raymond James maintains Strong Buy on Liquidia shares, $29 target - Investing.com
Liquidia (LQDA) Stock Rating and Price Target Maintained by Need - GuruFocus
Liquidia Faces Patent Litigation Filed by United Therapeutics - marketscreener.com
Where Liquidia Stands With Analysts - Benzinga
LQDA: HC Wainwright & Co. Reiterates Buy Rating with $29 Target - GuruFocus
Liquidia Says New Litigation Filed Against Co In U.S. - marketscreener.com
Liquidia (LQDA) Faces Patent Infringement Lawsuit from United Th - GuruFocus
Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics - The Manila Times
Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics - GlobeNewswire Inc.
Liquidia (NASDAQ:LQDA) Price Target Raised to $29.00 - Defense World
Analysts Are Updating Their Liquidia Corporation (NASDAQ:LQDA) Estimates After Its First-Quarter Results - simplywall.st
Liquidia (LQDA) Sees Increased Price Target by Raymond James | L - GuruFocus
Raymond James Boosts Price Target for Liquidia (LQDA) | LQDA Sto - GuruFocus
Raymond James Boosts Price Target for Liquidia (LQDA) | LQDA Stock News - GuruFocus
Liquidia Corp (LQDA) Q1 2025 Earnings Call Highlights: Strategic - GuruFocus
Liquidia Corp (LQDA) Q1 2025 Earnings Call Highlights: Strategic Advances and Legal Wins Propel ... - Yahoo Finance
Liquidia Corp (LQDA) Q1 2025 Earnings Call Highlights: Strategic Advances and Legal Wins Propel Erepia's Market Readiness - GuruFocus
Decoding Liquidia Corp (LQDA): A Strategic SWOT Insight - GuruFocus
Transcript : Liquidia Corporation, Q1 2025 Earnings Call, May 08, 2025 - marketscreener.com
Buckley Capital’s Views on Liquidia Corp. (LQDA) - Insider Monkey
Liquidia Corp (LQDA)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX
Earnings call transcript: Liquidia Technologies sees Q1 2025 net loss widen - Investing.com
Liquidia Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Liquidia Corp Reports Q1 2025 Earnings: EPS Misses at -$0.45, Revenue Falls Short at $3.1 Million - GuruFocus
LQDA Reports Q1 Revenue and Awaits FDA Decision on YUTREPIA | LQDA Stock News - GuruFocus
Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update - TradingView
Liquidia Corporation Provides Corporate Update and Financial Results Ahead of May 24 FDA Decision on YUTREPIA™ NDA - Nasdaq
Earnings Flash (LQDA) Liquidia Posts Q1 Net Loss $0.45 a Share, vs. FactSet Est of $0.39 Loss - marketscreener.com
Earnings To Watch: Liquidia Corp (LQDA) Reports Q1 2025 Result - Yahoo Finance
Liquidia Corporation to Present at BofA Securities 2025 Health Care Conference - The Manila Times
Liquidia Executives to Reveal Latest Cardiopulmonary Disease Strategy at Major BofA Healthcare Conference - Stock Titan
Liquidia Fends Off Indication Challenge In UTC Tyvaso Fight - Law360
Scotiabank raises Liquidia stock price target to $36 By Investing.com - Investing.com Canada
Liquidia (LQDA) Receives Price Target Upgrade from Scotiabank | - GuruFocus
Liquidia (LQDA): Scotiabank Raises Price Target and Maintains Ou - GuruFocus
Liquidia Corporation: A Strong Buy On High Likelihood Of FDA Approval This Month - Seeking Alpha
UTC can't counterclaim over amended Liquidia drug application, US judge says - MLex
Liquidia (LQDA) Receives Price Target Upgrade from Scotiabank | LQDA Stock News - GuruFocus
Scotiabank raises Liquidia stock price target to $36 - Investing.com
District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia - The Manila Times
Legal Victory for Liquidia Corporation (LQDA) in YUTREPIA Inhalation Powder Case | LQDA Stock News - GuruFocus
Liquidia Technologies stock surges on legal win By Investing.com - Investing.com Nigeria
Liquidia Technologies stock surges on legal win - Investing.com Australia
Liquidia (LQDA) Clears Legal Hurdle, Prepares for Yutrepia Launch | LQDA Stock News - GuruFocus
Liquidia (LQDA) Jumps 15% as Court Clears Path for Yutrepia Launch - GuruFocus
Liquidia (LQDA) Price Target Increased Following Legal Victory | LQDA Stock News - GuruFocus
UTC Bid to Delay Liquidia’s Yutrepia Launch Shot Down by Judge - Bloomberg Law News
Liquidia surges 15% as court clears way for Yutrepia launch (updated) - Seeking Alpha
Deeper Dive: Understanding Liquidia Corp (LQDA) Through its Various Ratios - DWinneX
Did Liquidia Corp (LQDA) perform well in the last session? - uspostnews.com
Liquidia Corp (LQDA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.10%
자본화:
|
볼륨(24시간):